
Artivion, a prominent manufacturer of cardiac implants and devices, experienced a significant ransomware attack on November 21, which led to the acquisition and encryption of its critical files. This incident caused major disruptions in the company’s ordering and shipping processes, along with certain corporate operations. Although Artivion managed to mitigate the immediate impact, it incurred unplanned expenses related to the